Format

Send to

Choose Destination
Cancer Manag Res. 2019 Mar 19;11:2189-2202. doi: 10.2147/CMAR.S175886. eCollection 2019.

Defining unmet clinical need across the pathway of brain tumor care: a patient and carer perspective.

Author information

1
Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK, will.a.sage@gmail.com.
2
Department of Neurosurgery, The Walton Centre, Liverpool, UK.
3
Mountain Hare Consulting, London, UK.
4
The Brain Tumour Charity, Farnborough, UK.
5
Brainstrust, Cowes, Isle of Wight, UK.
6
Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Abstract

Objective:

The aim of this study was to determine the experience of patients with brain tumors and their carers across distinct parts of their treatment pathway and identify their views on potential service gaps in need of addressing.

Methods:

A structured survey was administered at patient workshops across the UK and online through a charity newsletter. Answers to closed questions were analyzed using descriptive statistics, and open questions were examined using techniques of inductive content analysis.

Results:

A total of 136 survey responses were received, representing patients with a variety of diagnoses and geographical locations (30 counties). There was a wide range of opinions on the provision of current neuro-oncology services. Key themes identified included a perceived lack of information provision, a gap in postdischarge psychological and neuropsychological supports, and an unmet willingness for involvement in research.

Conclusion:

This national survey enhances our knowledge of current patient and carer experience within neuro-oncology services. A number of areas of unmet clinical need are highlighted providing a basis for informing future patient-centered service improvements and research.

KEYWORDS:

brain cancer; brain tumors; neuro-oncology pathway; patient experience

Conflict of interest statement

Disclosure AJJ is the director of Obex Technologies Ltd, lead partner of the DAMSEL project consortium. AJJ, MB, and JDP are core members of the NIHR Brain Injury Health Technology Co-operative. AJJ is supported by an NIHR Academic Clinical Lectureship award. FMW is supported by an NIHR Clinical Scientist award. The authors report no other conflicts of interest in this work.

Supplemental Content

Full text links

Icon for Dove Medical Press Icon for PubMed Central
Loading ...
Support Center